The pharmacokinetic analysis of large molecule therapeutics presents unique challenges. Ligand-binding assays are typically employed due to the specificity of capture and detection antibodies for the analyte as well as the sensitivity that can be achieved over LC-MS/MS assays. AIT Bioscience can support your PK/TK study from discovery phase through clinical trials. Our processes are modeled after industry standard white papers with acceptance criteria specifically for ligand-binding assays.
For more information about AITB pharmacokinetic study processes, contact us by email or phone at 317-715-8800.